Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Hassan, Hassan Elsiddig ^a   Mohamed, Ahmed Abdel Badie ^b   Bakhiet, Amel Omer ^a   Ahmed, Hussain Gadelkarim ^c  

^a SUDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Sudan)

^b Ahfad University for Women   (Sudan)

^c UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

Bladder cancer; COX2; iNOS; Schistosomiasis

Indexed keywords

CYCLOOXYGENASE 2; FORMALDEHYDE; INDUCIBLE NITRIC OXIDE SYNTHASE; PARAFFIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER PROGNOSIS; CONTROLLED STUDY; CYSTITIS; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMIASIS; SQUAMOUS CELL CARCINOMA; SUDAN; TRANSITIONAL CELL CARCINOMA; URINARY SCHISTOSOMIASIS;

EID: 84873719881     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-9     Document Type: Article

References (28)

1. Ferlay J, Bray F, Pisan P, Parkin DM, Globocan, Cancer incidence, mortality and prevalence worldwide (2002), version 1.0. IARC Cancer Base No. 5 Lyoo: IARC press 2004
2. Bladder cancer in Africa. Heyns CF, Van der Merwe A, Can J Urol 2008 15 3899 3908 18304401
3. Bilharziasis and bladder cancer: a time trend analysis of 9843 patients. Gouda I, Mokhtar N, Bilal D, El-Bolkainy T, El-Bolkainy NM, J Egypt Natl Canc Inst 2007 19 158 162 19034337
4. The changing patterns of bladder cancer in Egypt over the past 26 years. Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M, Cancer Causes Control 2008 19 421 429 10.1007/s10552-007-9104-7 18188671
5. Cyclooxygenase 2 Inhibitors in Cancer treatment and prevention: a recent development. Yu XC, Anti Cancer Drug 2002 13 127 137 10.1097/00001813-200202000- 00003 (Pubitemid 34183641)
6. Molecular oncology, Marker, Clinical Correlates: Cyclooxygenase 2 Expression is up-regulated in transitional cell carcinoma and its Preneoplastic Lesions in the human urinary bladder. Shirahama T, Clin Cancer Res 2000 6 2424 2430 10873095 (Pubitemid 30399211)
7. Cyclooxygenase 2 expression in human colon cancer cells increases metastatic potential. TsuJii M, Kawano S, Dubios RW, Proc Natl Acad Sci USA 1997 94 3336 3340 10.1073/pnas.94.7.3336 9096394 (Pubitemid 27157312)
8. Cyclooxygenase-2 Parallels invasive depth and increased MVD in transitional cell carcinoma. Li GO, Yang T, Li L, Yan J, Zeng Y, Yu J, Cell surf Biointer 2004 37 9 15 10.1016/j.colsurfb.2004.06.006 (Pubitemid 39164188)
9. Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder. Wadhwa P, Goswami AK, Joshi K, Sharma SK, Int Urol Nephrol 2005 37 47 53 10.1007/s11255-004-4699-z 16132759 (Pubitemid 41236242)
10. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Palacios M, Knowles RG, Palmer RM, Moncada S, Biochem Biophy Res Commun 1989 165 802 809 10.1016/S0006-291X(89)80037-3 (Pubitemid 20025593)
11. Regulation of biosynthesis of nitric oxide. Nathan C, Xie QW, J Biol Chem 1994 269 13725 13728 7514592 (Pubitemid 24191108)
12. Nitric oxide 9 years on. Bhagat K, Vallance P, J R Soc Med 1996 89 667 673 9014875 (Pubitemid 27026239)
13. Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis. Lin Z, Chen S, Ye C, Zhu S, Urol Res 2003 31 232 235 10.1007/s00240-003-0302-9 12937869 (Pubitemid 37122166)
14. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. Swana HS, Smith SD, Perrotta PL, Saito N, Wheeler MA, Weiss RM, J Urol 1999 161 630 634 10.1016/S0022-5347(01)61985-2 9915473
15. Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder. El Gehani K, Al-Kikhia L, Emaetig F, Syrjänen K, Al-Fituri O, Elzagheid A, Libyan J Med 2012 7 10
16. Epidemiology and etiology of bladder cancer. Johansson SL, Cohen SM, Semin Surg Onco 1997 13 291 298 10.1002/(SICI)1098-2388(199709/10)13:5<291:: AID-SSU2>3.0.CO;2-8 (Pubitemid 27332851)
17. Pattern of bladder cancer in the Sudan and its relation to schistosomiasis: a study of 255 vesical carcinomas. Malik MO, Veress B, Daoud EH, J Trop Med Hyg 1975 78 219 223 1214307
18. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors. Abdulamir AS, Hafidh R, Kadhim HS, Abubakar F, Clin Cancer Res 2009 28 27 10.1186/1756-9966-28-27
19. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Harris L, Fritsche H, Mennel R, J Clin Oncol 2007 25 5287 5312 10.1200/JCO.2007.14.2364 17954709 (Pubitemid 350232263)
20. Overexpression of Cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Shirahama T, Sakakura C, Clinical Cancer Res 2001 7 558 561 (Pubitemid 32707978)
21. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T, APMIS 2009 117 45 52 10.1111/j.1600-0463.2008.00014.x 19161536
22. Possible Role of Cyclooxygenase-2 in Schistosomal and Non-Schistosomal-Associated Bladder Cancer. Hammam OA, Ahmed AA, Mamdouh SR, Ahmed MAH, Medscape J Med 2008 10 234 237
23. Bilharzial versus non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression. Youssef R, Kapur P, Kabbani W, Shariat SF, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y, BJU Int 2011 108 1 31 37 10.1111/j.1464-410X.2010.09854.x 21105986
24. Nitric oxide: physiology, pathophysiology, and pharmacology. Moncada S, Palmer RMJ, Higgs EA, Pharmacol Rev 1991 43 109 142 1852778
25. Nitric oxide: a physiologic messenger molecule. Bredt DS, Snyder SH, Annu Rev Biochem 1994 63 175 195 10.1146/annurev.bi.63.070194.001135 7526779
26. Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peri tumoral normal mucosa. Chhatwal VJS, Ngoi SS, Chan STF, Carcinogenesis 1994 15 2081 2085 10.1093/carcin/15.10.2081 7525094
27. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Jenkins DC, Charles IG, Baylis SA, Br J Cancer 1994 70 847 849 10.1038/bjc.1994.409 7524602 (Pubitemid 24331075)
28. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S, Wanibuchi H, Int J Cancer 2008 123 3 601 608 10.1002/ijc.23547 18478569 (Pubitemid 351898418)